Compare UTMD & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTMD | OSUR |
|---|---|---|
| Founded | 1978 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.4M | 214.1M |
| IPO Year | 1994 | 2000 |
| Metric | UTMD | OSUR |
|---|---|---|
| Price | $62.64 | $2.94 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 10.0K | ★ 433.0K |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | ★ 1.98% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.68 | N/A |
| Revenue | $40,903,000.00 | ★ $167,064,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | $23.37 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $51.27 | $2.08 |
| 52 Week High | $68.71 | $4.22 |
| Indicator | UTMD | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 41.78 | 51.43 |
| Support Level | $60.00 | $2.69 |
| Resistance Level | $64.21 | $2.99 |
| Average True Range (ATR) | 1.69 | 0.19 |
| MACD | -0.65 | -0.00 |
| Stochastic Oscillator | 9.43 | 64.58 |
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.